Rooted Wealth Advisors Inc. Has $482,000 Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Rooted Wealth Advisors Inc. boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 6.3% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 918 shares of the healthcare conglomerate’s stock after buying an additional 54 shares during the period. Rooted Wealth Advisors Inc.’s holdings in UnitedHealth Group were worth $482,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. Fulcrum Capital LLC boosted its stake in UnitedHealth Group by 6.4% during the first quarter. Fulcrum Capital LLC now owns 24,013 shares of the healthcare conglomerate’s stock worth $12,577,000 after buying an additional 1,452 shares in the last quarter. Somerset Trust Co lifted its holdings in shares of UnitedHealth Group by 6.2% during the first quarter. Somerset Trust Co now owns 6,983 shares of the healthcare conglomerate’s stock valued at $3,657,000 after acquiring an additional 410 shares during the period. IFG Advisors LLC bought a new position in shares of UnitedHealth Group during the first quarter valued at $200,000. Retirement Wealth Solutions LLC lifted its holdings in shares of UnitedHealth Group by 55.0% during the first quarter. Retirement Wealth Solutions LLC now owns 186 shares of the healthcare conglomerate’s stock valued at $97,000 after acquiring an additional 66 shares during the period. Finally, S.E.E.D. Planning Group LLC lifted its holdings in shares of UnitedHealth Group by 7.0% during the first quarter. S.E.E.D. Planning Group LLC now owns 11,433 shares of the healthcare conglomerate’s stock valued at $5,988,000 after acquiring an additional 748 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other news, CEO Stephen J. Hemsley bought 86,700 shares of the business’s stock in a transaction on Friday, May 16th. The shares were purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the purchase, the chief executive officer now owns 679,493 shares of the company’s stock, valued at approximately $196,081,295.01. The trade was a 14.63% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Kristen Gil bought 3,700 shares of the business’s stock in a transaction on Thursday, May 15th. The stock was purchased at an average price of $271.17 per share, for a total transaction of $1,003,329.00. Following the purchase, the director now directly owns 3,818 shares in the company, valued at approximately $1,035,327.06. This represents a 3,135.59% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 109,408 shares of company stock worth $31,607,768. Corporate insiders own 0.33% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on UNH shares. Wolfe Research cut their price objective on UnitedHealth Group from $501.00 to $390.00 and set an “outperform” rating for the company in a report on Tuesday, May 20th. Mizuho cut their price objective on UnitedHealth Group from $515.00 to $350.00 and set an “outperform” rating for the company in a report on Friday, May 16th. Wall Street Zen cut UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Robert W. Baird cut their price target on UnitedHealth Group from $510.00 to $356.00 and set an “outperform” rating for the company in a report on Wednesday, May 14th. Finally, TD Cowen cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price target for the company. in a report on Monday, May 19th. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and seventeen have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $441.87.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $301.08 on Friday. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The business has a 50-day moving average of $430.87 and a 200-day moving average of $494.23. UnitedHealth Group Incorporated has a 1 year low of $248.88 and a 1 year high of $630.73. The firm has a market capitalization of $273.12 billion, a P/E ratio of 19.42, a PEG ratio of 1.37 and a beta of 0.56.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the firm posted $6.91 earnings per share. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.